Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial

Overview of attention for article published in Clinical Cancer Research, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 21 news outlets
blogs: 3 blogs
twitter: 4 X users

patent: 5 patents
facebook: 8 Facebook pages

Readers on

mendeley: 96 Mendeley

So far, Altmetric has seen 3 posts from 3 blogs.

Bioengineering innate immune cells

Springer Nature Research Communities, 14 Jun 2025

From immunomodulation to immunotherapy

Promising initial results for HER2-positive breast cancer vaccine

Oncology Central, 06 Jan 2017

A recent study from a team at Moffitt Cancer Center (FL, USA), published in Clinical Cancer Research, has highlighted the…

New Breast Cancer Vaccine Shows Promise In Curbing Deadly Disease

Counsel & Heal : Top News, 05 Jan 2017

Researchers have created a new immune vaccine intended to fight and kill breast cancer cells.

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.